Prestige Consumer Healthcare (PBH) Fails to deliver data

Key failure to deliver metrics for Prestige Consumer Healthcare:

• Last SEC data release: 2024-10-11
• Last 15 days FTD volume: NZ$0.01 M
• Last 3 months FTD volume: NZ$1.37 M
• Last year FTD volume: NZ$1.37 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Prestige Consumer Healthcare (PBH) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Prestige Consumer Healthcare (PBH) - since 2013

Prestige Consumer Healthcare (PBH) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
GlaxoSmithKline GSK	NZ$25.51 M	NZ$53.86 M	🇬🇧 UK
Pfizer PFE	NZ$0.18 B	NZ$0.53 B	🇺🇸 USA
Rite Aid RAD	NZ$12.18 M	NZ$30.91 M	🇺🇸 USA
Johnson & Johnson JNJ	NZ$70.4 M	NZ$0.32 B	🇺🇸 USA
Taro Pharmaceutical TARO	N/A	NZ$1.1 M	🇮🇱 Israel
Novartis NVS	NZ$16.44 M	NZ$78.49 M	🇨🇭 Switzerland
Procter & Gamble PG	NZ$30.02 M	NZ$0.11 B	🇺🇸 USA
CVS Health CVS	NZ$32.87 M	NZ$0.18 B	🇺🇸 USA
Clorox CLX	NZ$5.07 M	NZ$20.41 M	🇺🇸 USA
Abbott Laboratories ABT	NZ$25.63 M	NZ$0.14 B	🇺🇸 USA